Remove Blogging Remove Doc Remove Funding Remove Venture Capital
article thumbnail

Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists

Xconomy

Telemedicine isn’t just another way to connect patients with doctors. AristaMD has carved out a niche in connecting doctors with, well, other doctors.

Doc 84
article thumbnail

One Man’s Signal is Another Man’s Noise

Both Sides of the Table

It’s apropos because there is so much noise these days with email, Twitter, Facebook, blogs, web shows, etc. I was thinking back to a few previous “insider baseball&# blog debates that raged for several weeks: AngelGate (aka Bin38 secret cabal), convertible debt vs. equity, bubble vs. not, and now the AngelList discussion.

Email 287
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Entrepreneur’s Don’t Think Enough. Here’s What You Can Do About It …

Both Sides of the Table

And I get flooded with legal docs, end-of-quarter financial administration, recruiting, whatever. Frankly, I think venture capital is that way, too. How do VCs break out of group think when they are shuttling from one board meeting to the next, from one conference to the other and talking with all the same people?

article thumbnail

Going to Raise VC? Here’s a Primer on Process, People, Deck

Both Sides of the Table

If you want a very quick primer on all the stuff nobody ever tells you about raising venture capital check out this video where Mark Jeffrey & I break it down on This Week in VC. All of this is covered in more detail on the TWiVC video above (and much of it is covered in text on this blog on the “ Raising VC &# tab).

article thumbnail

Guide to the LA Startup Community

SoCal Delicious

Southern California companies are second to only Silicon Valley in raising venture capital , there are three major universities to recruit talent – UCLA, Caltech, and USC – and a thriving startup community to mingle with. He blogs here and tweets here. Not to mention the great weather, beaches, and beautiful people.

Guide 42
article thumbnail

Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More

Xconomy

Nearly four years after investors snapped up new shares of Juno Therapeutics in a $265 million IPO, cancer immunotherapy remains a hot ticket. Like Juno, Allogene Therapeutics just pulled in a massive IPO haul, nearly $300 million.

Doc 74
article thumbnail

INNOVATION - A Scientist's Perspective

AeA Los Angeles Council

Approximately 50 executives from the worlds of technology & venture capital piled into the dining hall on June 30th to listen to Dr. Mark Drapeau speak about "innovation" and its sister topic, "STEM education." The National Science Foundation mainly funds professors to do research. government. You can affect this process.